Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Misty Shields

Thoracic Oncology · IUSM

View

Dr. Gilberto Lopes

Thoracic Oncology · University of Miami

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Miksad

GI Oncology · BMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JSDr. Jacob Sands
    Leading Voice

    Dr. Jacob Sands

    Medical Oncology · Thoracic Oncology
    Dana-Farber Cancer Institute
    drjacobsands
    Boston, MA

    Research

    Quantitative gene-level inference of tumor transcription from plasma epigenomes

    2026

    Via Res Sq

    Research

    Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer

    2026

    Via bioRxiv

    Research

    Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications

    2026

    Via Mod Pathol

    Research

    Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer

    2026

    Via Br J Cancer

    Research

    A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study

    2026

    Via Cancer Epidemiol Biomarkers Prev

    Research

    The 2026 American Association for Thoracic Surgery Expert Consensus Document: Evaluation and management of N2+ non-small cell lung cancer

    2026

    Via J Thorac Cardiovasc Surg

    Research

    Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial

    2026

    Via JAMA

    Research

    Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial

    2026

    Via Lancet Respir Med

    Research

    T-cell engagers in small cell lung cancer

    2026

    Via Cancer

    Research

    Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer

    2026

    Via Target Oncol

    Research

    Minimalistic, disposable wireless electrochemical sensors: Integrating self-powered amperometry with direct inductive coupling

    2025

    Via Biosens Bioelectron

    Research

    Proceedings of the 1st biannual bridging the gaps in lung cancer conference

    2025

    Via The Oncologist

    Research

    Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study

    2025

    Via Journal of Clinical Oncology

    Research

    NCCN Guidelines Insights: Lung Cancer Screening, Version 1.2025

    2025

    Via Journal of the National Comprehensive Cancer Network

    Research

    Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer

    2025

    Via Cancer